Clinical Trial Update: Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in Participants With ADHD & Comorbid Dyslexia [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the impact of atomoxetine on brain activation during attention and reading tasks in participants with ADHD and comorbid dyslexia; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Dyslexia

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Hyperactivity Disorder, Dyslexia | Phase 4 | Status: COMPLETED | Results posted: 2018-02-07